The TJX Companies, Inc. (LON:0LCE)

CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Feb 1, 2025	Feb 3, 2024	Jan 28, 2023	Jan 29, 2022	Jan 30, 2021
Market Capitalization	106,120	112,860	87,909	76,424	63,421	56,058
Market Cap Growth	26.44%	28.38%	15.03%	20.50%	13.14%	4.10%
Enterprise Value	112,769	119,292	94,419	83,902	67,913	59,747
Last Close Price	95.15	100.64	75.81	64.05	49.75	44.64
PE Ratio	29.21	28.84	24.84	27.05	25.94	854.32
PS Ratio	2.48	2.49	2.05	1.90	1.75	2.39
PB Ratio	16.59	16.71	15.22	14.87	14.18	13.18
P/TBV Ratio	16.78	17.13	15.65	15.39	14.72	13.71
P/FCF Ratio	-	33.42	25.64	36.02	42.32	19.25
P/OCF Ratio	-	22.94	18.35	23.17	27.85	16.85
EV/Sales Ratio	2.62	2.63	2.20	2.08	1.88	2.55
EV/EBITDA Ratio	13.45	20.02	17.65	18.08	16.22	56.40
EV/EBIT Ratio	23.79	23.53	20.59	21.38	19.18	140.81
EV/FCF Ratio	39.69	35.32	27.53	39.54	45.32	20.52
Debt / Equity Ratio	1.54	1.52	1.72	2.00	2.08	2.66
Debt / EBITDA Ratio	1.18	1.16	1.22	1.41	1.40	3.49
Debt / FCF Ratio	3.46	3.04	2.89	4.85	6.22	3.88
Asset Turnover	1.85	1.83	1.87	1.76	1.64	1.17
Inventory Turnover	5.94	6.32	6.44	6.14	6.74	5.33
Quick Ratio	0.45	0.54	0.59	0.60	0.66	1.01
Current Ratio	1.16	1.18	1.21	1.21	1.27	1.46
Return on Equity (ROE)	60.36%	61.98%	65.48%	56.57%	55.48%	1.53%
Return on Assets (ROA)	12.75%	12.81%	12.47%	10.69%	10.03%	1.32%
Return on Capital (ROIC)	18.82%	19.21%	18.60%	16.15%	14.92%	1.88%
Return on Capital Employed (ROCE)	29.90%	30.40%	30.00%	26.90%	26.40%	2.90%
Earnings Yield	3.42%	3.47%	4.03%	3.70%	3.86%	0.12%
FCF Yield	2.68%	2.99%	3.90%	2.78%	2.36%	5.20%
Dividend Yield	0.96%	1.20%	1.39%	1.49%	1.56%	0.43%
Payout Ratio	35.03%	33.88%	33.17%	38.28%	38.14%	308.89%
Buyback Yield / Dilution	1.36%	1.47%	1.61%	3.13%	-0.08%	0.94%
Total Shareholder Return	2.32%	2.67%	3.00%	4.61%	1.47%	1.36%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.